Blood testing could spot cancer early, study says
May 9 (UPI) -- Blood tests could catch as many as half of cancers at an earlier, more treatable stage, a new study says.
If conducted every year or every other year, the multi-cancer early detection blood test could help more people survive cancer, researchers reported Thursday in BMJ Open.
"Both annual and biennial MCED screening intervals have the potential to avert deaths associated with late-stage cancers when used in addition to current guideline-based cancer screening," concluded a research team led by Peter Sasieni, a professor of cancer epidemiology with Queen Mary University of London.
The blood test looks for many different cancer-specific signals, including DNA fragments shed by tumors, researchers said.
Only a few screenings today can reliably detect cancer among those at high risk, including tests for breast, colon, cervical and lung cancers, researchers said.
Blood testing offers an opportunity to detect dozens of different cancer types by looking for cancer markers in people's bloodstream.
To estimate the usefulness of blood testing in regular cancer screening, researchers analyzed data from an earlier clinical trial that used the blood test to help diagnose cancer.
The analysis showed that blood testing improved early diagnosis for a wide variety of cancers.
Compared with standard cancer screening, annual blood testing was associated with 49% fewer late-stage cancer diagnoses and 21% fewer deaths within five years, results show.
Blood testing every other year resulted in 39% fewer late-stage diagnoses and 17% fewer deaths within five years, researchers added.
Among people diagnosed with an aggressive, fast-growing cancer, blood tests could avert 14% to 21% deaths within five years, results show.
"Based on the performance characteristics from a case control study, both annual and biennial screening with an MCED test have the potential to intercept 31% to 49% of cancers at stage 1-2 that would otherwise present at stage 3-4," researchers estimate.
"Of these, approximately equal numbers would be detected at stage 1 and at stage 2," they added.
These estimates assume complete compliance with screening schedules and follow-up testing, which is optimistic, researchers noted. They also assume that more early-stage diagnoses will automatically reduce death rates.
"The optimal choice of screening interval will depend on assessments of real-world cancer survival and the costs of confirmatory testing after MCED screening," researchers said.
More information
The Cleveland Clinic has more on blood tests for cancer.
Copyright © 2025 HealthDay. All rights reserved.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
3 hours ago
- Newsweek
Long-Term Use of This Contraceptive Pill Linked to Increased Brain Tumor Risk
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Using the progestogen-only contractive pill "desogestrel" for more than five years may increase the risk of developing a type of brain tumor known as an "intracranial meningioma," a new study has warned. The researchers noted that the risk is low—and is eliminated one year after desogestrel treatment is suspended—but that doctors' awareness of the possibility could eliminate the need for surgery in some cases. Meningiomas are a rare, non-cancerous form of tumor that arise from the membranes surrounding the brain. While slow-growing and benign in and of themselves, they can develop to a size that compresses other structures in the brain. They usually only require surgery when they cause symptoms such as persistent headaches or neurological issues. Woman holding combined oral contraceptive pill. Woman holding combined oral contraceptive pill. PATCHARIN SIMALHEK The study, based on data from France's national health system, compared over 8,000 women who underwent surgery for meningioma between 2020 and 2023 with more than 83,000 matched controls. Researchers found that women who had taken desogestrel continuously for more than five years had a slightly elevated risk of developing the brain tumors. Reassuringly, no increased risk was found for short-term use or for other commonly used progestogens like levonorgestrel, either alone or combined with estrogen. "This large study using French national database... shows [an] association between taking a certain progestogen (desogestrel) continuously for more than five years and meningioma risk, however, the magnitude of increase in the risk is small," said paper author Dr. Mangesh Thorat of Queen Mary University of London in a statement. Short-term use does not increase risk and the risk ceases after stopping use, he added. The authors estimate that one woman in every 67,000 using desogestrel would need surgery for meningioma and this drops to 1 in 17,000 with continuous use beyond five years. By comparison, breast cancer is about 10 times more common than meningioma. To understand progestogens, Thorat said it's crucial to note that the effects of different drug formulations can vary significantly and individual drugs can affect various organs differently. "Therefore, it is important to consider which specific drug is being used by an individual," he said. The study also showed that Microgynon and the morning-after pill—both containing levonorgestrel—were not linked to increased risk. Still, the findings have clinical relevance, especially for women over 45 or those with a prior history of using other high-risk progestogens. In such cases, the study suggests discontinuing desogestrel if a meningioma is identified, rather than jumping straight to surgery. "Stopping desogestrel may also avoid unnecessary potentially harmful treatments," said neurosurgeon Gilles Reuter of the University Hospital Liegein an accompanying editorial. Reuter emphasized that similar results have already been seen with other high-risk progestogens. While the study is observational and cannot prove cause and effect, its large sample size adds weight to the findings. However, experts say the takeaway should be caution, not alarm. For those affected by the findings, Thorat advises speaking with a healthcare provider regarding which drug is being used. "If it is associated with an increased risk of meningioma, this can be changed to a safer alternative," he said. "There is no reason to panic as the risk is very small and even in those who developed meningioma, stopping the specific drug has shown to cause regression in the size of meningioma." Do you have a tip on a health story that Newsweek should be covering? Do you have a question about contraceptives? Let us know via health@ References Roland, N., Kolla, E., Baricault, B., Dayani, P., Duranteau, L., Froelich, S., Zureik, M., & Weill, A. (2025). Oral contraceptives with progestogens desogestrel or levonorgestrel and risk of intracranial meningioma: National case-control study. BMJ, 389. Reuter, G. (2025). Progestogens and meningioma: New evidence on levonorgestrel and desogestrel. BMJ, 389.
UPI
7 hours ago
- UPI
Watch: Gaal takes on the Mule in 'Foundation' Season 3 trailer
1 of 3 | Apple TV+ is previewing Season 3 of "Foundation." Photo courtesy of Apple TV+ June 11 (UPI) -- Voyagers actress Lou Llobell and Game of Thrones actor Pilou Asbaek prepare to face off in a new trailer for Foundation Season 3, released Wednesday. Llobell portrays Gaal in the sci-fi series inspired by the Isaac Asimov novels. Asbaek joins the cast as the Mule, a warlord who poses "a threat to the entire galaxy," according to an official synopsis. "You think I'm a monster?" he asks in the preview. "I have talents, you see. I can worm my way into people's minds. Convert enemies into allies. Hate into love." Hari (Jared Harris) tells Gaal that her battle is with the Mule. "It's my job to ensure you're prepared." he says. "The Mule's abilities are far beyond anything I can do," she responds. Season 3 takes place more than a century after Season 2, according to the synopsis. The upcoming chapter also stars Cherry Jones, Brandon P. Bell, Synnove Karlsen, Cody Fern, Tomas Lemarquis, Alexander Siddig, Troy Kotsur, Laura Birn, Cassian Bilton, Terrence Mann and Rowena King. Season 3 premieres July 11 on Apple TV+.
UPI
18 hours ago
- UPI
Childhood trauma linked to higher risk of endometriosis in adult women
1 of 2 | Endometriosis affects one in 10 women in the United States and can cause chronic and frequently severe pelvic pain. A new study has found that women who experienced childhood traumas are at heightened risk to develop the condition as adults. Photo by cottonbro studio/ Pexels ST. PAUL, Minn., June 11 (UPI) -- A suspected link between childhood trauma and the risk of developing endometriosis in later life was strengthened Wednesday with the publication of study that showed a greater chance of the condition among women with histories of difficult childhoods. The study of hundreds of thousands of women in Sweden found those who as children experienced substance abuse, had a teenage or mentally ill parent, financial problems or a death in the family were linked to a 20% increased risk of an endometriosis diagnosis compared to women who had not been exposed. However, the risk was much greater for girls exposed more than one of those factors, rising to 60%, while those who witnessed or were subjected to violence saw more than twice the risk of developing endometriosis later in life compared to women who had not been exposed, the Swedish authors reported. The study published in the British medical journal Human Reproduction builds on earlier findings that women who experienced physical and sexual abuse as children had a 79% higher risk of developing the painful condition, which affects one in 10 reproductive-age women in the United States. Lead author Dr. Marika Rostvall, a physician and doctoral student in the Department of Global Public Health at the Karolinska Institute in Stockholm, told UPI the findings provide more evidence of the strong connection between mental and physical health. The findings "support previous studies in other areas of medicine suggesting that the mind and body are intimately connected and that psychologically taxing events can have biological consequences," she said in emailed comments. Endometriosis usually affects women in their 20s and 30s, and while there are a handful known risk factors such as starting menstruation early and having a lean body type, the cause remains unknown. The problems stem from the behavior of tissues known as endometrium, which under normal circumstances are found only in the inner lining of a woman's uterus. Those tissues grow to a thick, blood vessel-rich layer during the menstrual cycle to prepare for possible implantation of an embryo, and then shed the blood at the end of the cycle if there is no embryo present. But in some cases, endometrium behave abnormally and start growing outside of the uterus. When they do so, they can attach themselves to the ovaries, fallopian tubes, bowel, bladder or other parts of the body, triggering frequently severe pelvic pain as they carry out their monthly thickening function. As a result, endometriosis can cause excessive bleeding and even infertility -- which is the case for up to half of women with the condition -- as well as cysts, scar tissue and adhesions. Those in turn can trigger chronic pain, including during with sexual intercourse as well as during urination or bowel movements. The Swedish researchers began by looking at the health records of more 1.3 million women born in in the country between 1974 and 2001, eventually narrowing it down to 24,000 who were diagnosed with endometriosis. They then tapped several national registers to track their childhood experiences, looking for evidence of trauma or difficulties, including crimes such as violence and sexual abuse. The results, they said, demonstrate the importance of considering "the whole person" not just the symptoms of endometriosis. The negative physical consequences of psychological trauma can perhaps be traced to a compromised ability of the immune system to protect against the condition, or even in how the body perceives pain, Rostvall said. "I think the immune system is an interesting part of the puzzle when it comes to trying to understand why some women develop endometriosis," she said. "Chronic inflammation is a big part of the disease, and it has also been shown that women with endometriosis have a higher incidence of autoimmune disorders compared to healthy women. "There is a lot of interesting research being done in the area, and a deeper understanding of exactly how the immune system functions in relation to endometriosis could potentially help bring forward new kinds of treatment." Like some other women's health issues, the pain of endometriosis is often dismissed and sufferers have reported negative experiences with healthcare professionals, often in the form of providers "trivializing" symptoms, which can cause feelings of loneliness and alienation. This, in turn, can make obtaining a diagnosis difficult and prompt some to choose to avoid engaging with doctors altogether. A British psychological-based study from last year showed some women who suffered symptoms felt they had experienced a form of "medical gaslighting" in which they were made to doubt their own perceptions of pain. Rostvall said these kinds of experiences are especially relevant when the patients are women who come from socially and psychologically traumatic backgrounds. "A lot of women presenting with pain, especially socioeconomically disadvantaged women and women with psychiatric comorbidities, who are more likely to have experienced childhood adversity, have their pain dismissed. They then have to wait for a long time to receive a diagnosis and treatment, potentially allowing the condition to worsen," she said. "I think physicians should be aware of the complex linkage between the mind and body in general and be more open to listening to their patients' stories, take their pain seriously, and offer a thorough physical examination."
